• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A call for unity: The path towards a more precise and patient-centric nomenclature for NAFLD.

出版信息

J Hepatol. 2023 Jul;79(1):4-5. doi: 10.1016/j.jhep.2023.05.003. Epub 2023 May 22.

DOI:10.1016/j.jhep.2023.05.003
PMID:37224924
Abstract
摘要

相似文献

1
A call for unity: The path towards a more precise and patient-centric nomenclature for NAFLD.团结的呼声：通往更精确且以患者为中心的非酒精性脂肪性肝病命名法之路。
J Hepatol. 2023 Jul;79(1):4-5. doi: 10.1016/j.jhep.2023.05.003. Epub 2023 May 22.
2
A call for unity: The path towards a more precise and patient-centric nomenclature for NAFLD.团结的呼声：迈向更精确且以患者为中心的非酒精性脂肪性肝病命名法之路。
Hepatology. 2023 Jul 1;78(1):3-5. doi: 10.1097/HEP.0000000000000412. Epub 2023 May 22.
3
A call for unity: The path towards a more precise and patient-centric nomenclature for NAFLD.团结的呼声：迈向更精确且以患者为中心的非酒精性脂肪性肝病命名法的道路。
Ann Hepatol. 2023 Jul-Aug;28(4):101115. doi: 10.1016/j.aohep.2023.101115. Epub 2023 May 22.
4
From NAFLD to MAFLD: Nurse and allied health perspective.从非酒精性脂肪性肝病到代谢功能障碍相关脂肪性肝病：护士及相关健康专业人员的视角
Liver Int. 2021 Apr;41(4):683-691. doi: 10.1111/liv.14788. Epub 2021 Feb 2.
5
Not all NAFLD patients are the same: We need to find a personalized therapeutic approach.并非所有非酒精性脂肪性肝病患者都一样：我们需要找到个性化的治疗方法。
Dig Liver Dis. 2019 Jan;51(1):176-177. doi: 10.1016/j.dld.2018.10.009. Epub 2018 Oct 23.
6
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD：代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
7
Referral care paths for non-alcoholic fatty liver disease-Gearing up for an ever more prevalent and severe liver disease.非酒精性脂肪性肝病的转诊护理路径——为日益普遍和严重的肝病做好准备。
United European Gastroenterol J. 2021 Oct;9(8):903-909. doi: 10.1002/ueg2.12150. Epub 2021 Oct 5.
8
Mitochondria-Mediated Pathogenesis and Therapeutics for Non-Alcoholic Fatty Liver Disease.线粒体介导的非酒精性脂肪肝病发病机制与治疗学
Mol Nutr Food Res. 2019 Aug;63(16):e1900043. doi: 10.1002/mnfr.201900043. Epub 2019 Jun 19.
9
Exploring the Path of Mediterranean Diet, Non-Alcoholic Fatty Liver Disease (NAFLD) and Inflammation towards 10-Year Cardiovascular Disease (CVD) Risk: The ATTICA Study 10-Year Follow-Up (2002-2012).探讨地中海饮食、非酒精性脂肪性肝病 (NAFLD) 和炎症与 10 年心血管疾病 (CVD) 风险之间的关系：ATTICA 研究 10 年随访 (2002-2012)。
Nutrients. 2022 Jun 7;14(12):2367. doi: 10.3390/nu14122367.
10
[Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases].[非酒精性脂肪性肝病命名对合并其他肝脏疾病的脂肪性肝病诊疗的影响]
Zhonghua Gan Zang Bing Za Zhi. 2023 Aug 20;31(8):805-809. doi: 10.3760/cma.j.cn501113-20230810-0050.

引用本文的文献

1
Health and Liver Diagnostic Markers Influencing Glycemia in Subjects with Prediabetes: Preview Study.影响糖尿病前期患者血糖的健康与肝脏诊断标志物：前瞻性研究
Diagnostics (Basel). 2024 Dec 23;14(24):2895. doi: 10.3390/diagnostics14242895.
2
Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification.脂肪性肝病所致肝细胞癌的风险及其新提出的亚分类
Liver Cancer. 2024 Mar 12;13(5):561-571. doi: 10.1159/000538301. eCollection 2024 Oct.
3
Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name?非酒精性脂肪性肝病与代谢相关脂肪性肝病与代谢功能障碍相关脂肪性肝病：名称里有什么含义？
Euroasian J Hepatogastroenterol. 2024 Jan-Jun;14(1):1-4. doi: 10.5005/jp-journals-10018-1424.
4
Polymorphisms Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver Disease.与代谢功能障碍相关脂肪性肝病相关的多态性影响终末期肝病的进展。
Gastro Hep Adv. 2024;3(1):67-77. doi: 10.1016/j.gastha.2023.09.011. Epub 2023 Oct 5.
5
Host microbiome associated low intestinal acetate correlates with progressive NLRP3-dependent hepatic-immunotoxicity in early life microcystin-LR exposure.宿主微生物组相关的低肠道乙酸盐与早期生活中小菌素-LR 暴露时 NLRP3 依赖性肝免疫毒性的进展相关。
BMC Pharmacol Toxicol. 2023 Dec 13;24(1):78. doi: 10.1186/s40360-023-00721-7.